AndreaBozzo/ceres-open-data-index huggingface dataset:
Compound 525403: Isopropyl n-butyl disulphide

Chemical compound data from PubChem database. IUPAC Name: 1-(propan-2-yldisulfanyl)butane. Molecular Formula: C7H16S2. Molecular Weight: 164.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
NNDSS - TABLE 1G. Carbapenemase-producing carbapenem-resistant Enterobacteriaceae to Chancroid

NNDSS - Table 1G. Carbapenemase-producing carbapenem-resistant Enterobacteriaceae to Chancroid - 2019. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents. 

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html 

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published — CDC does not have data because of changes in how conditions are categorized.
Cum: Cumulative year-to-date counts.
Max: Maximum — Maximum case count during the previous 52 weeks.
* Case counts for reporting years 2018 and 2019 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the US, a US territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-US Residents' category. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf. 
† Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data). 
§ Data for Carbapenemase-producing Carbapenem-resistant enterobacteriaceae (CP-CRE) will be displayed in this table after the CDC obtains Office of Management and Budget Paperwork Reduction Act approval to receive data for this condition.
Compound 528912: Mandelic acid, 4-hydroxy, DCTFA-acetate

Chemical compound data from PubChem database. IUPAC Name: [4-[2,2-bis[chloro(difluoro)methyl]-5-oxo-1,3-dioxolan-4-yl]phenyl] acetate. Molecular Formula: C13H8Cl2F4O5. Molecular Weight: 391.1. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401359-T1: [Translated] HYBRID RESINS BASED ON POLYISOCYANATE AND WATERGLASS, COMPOSITE MATERIALS CONTAINING THEM AND PRODUCTION PROCESSES THEREOF

A new hybrid resin having improved mechanical and fracture mechanical properties is provided which contains polyisocyanate and/or blocked polyisocyanate, water glass and organic phosphoric acid ester and/or other plasticizer, characterized in that it also contains vinyl ester and/or polyester as resin component. The invention also relates to the composite produced using such hybrid resin and the processes for producing the resin and the composite.
Patent AT-E401052-T1: [Translated] COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING A COMBINATION OF GREEN DYE AND ANTI-INFLAMMATORY ACTIVE INGREDIENT

A cosmetic or dermatological composition contains by weight (a) a red light-filtering colorant (0.01-5%); and (b) an antiinflammatory agent (0.0001-10%). ACTIVITY : Dermatological; Antiinflammatory MECHANISM OF ACTION : None given in the specification.
Provider Network Data: 2023 Quarter 3

This Provider Network Data contains information on individual and institutional providers participating in health plan networks from July through September 2023. Plan network data is collected from Medicaid, Commercial, and Exchange plans on a quarterly basis by the Department of Health, including managed care plans, as well as PPO/EPO plans.

For more information, please visit: <a href=https://pndslookup.health.ny.gov>https://pndslookup.health.ny.gov</a>
Patent AT-E399574-T1: [Translated] ANESTHESIA SYRINGE

The invention relates to an anesthesia syringe (1). The aim of the invention is to provide an improved, very compact anesthesia syringe (1) that allows to carry out injections in a precise and reproducible manner. The inventive syringe is characterized in that at the back of an advance plunger (7) a first hydraulic chamber (16) and at the back of the first hydraulic chamber (16) a second hydraulic chamber (19) are provided and in that the hydraulic chambers (16, 19) are interlinked in a manner so as to be rheostatically controlled. The invention also relates to a special seat for needles that are specifically developed for the inventive syringe (1).
Projectile Fluid Penetration and Flammability of Respirators and other Head/Facial Personal Protective Equipment (FPFPPE)

The U.S. Food and Drug Administration (FDA) requires surgical masks (SMs) and surgical N95 respirators used in healthcare to meet certain fluid resistance and flammability levels. NIOSH’s National Personal Protective Technology Laboratory (NPPTL) investigated the fluid penetration and flammability of respirators and other head/facial personal protective equipment to determine their efficacy in reducing healthcare workers’ risk for occupational exposures to infectious microorganisms and injury due to accidental fires in surgical settings. The results from this study showed that FDA cleared SMs and surgical N95 respirators were resistant to synthetic blood penetration (Rengasamy et al. 2014) and met the flammability levels (Rengasamy et al. 2018) as expected. Seven out of eleven non-FDA cleared NIOSH-approved N95 filtering facepiece respirator models also passed the synthetic blood penetration and flammability tests. NPPTL tested five models of powered air-purifying respirator (PAPR) hoods and all models showed
Patent AT-E400146-T1: [Translated] TRANSMISSION OF GSM CELL BROADCAST SMS MESSAGES IN CDMA COMMUNICATION SYSTEMS

Techniques to send GSM CBS messages over a CDMA air interface. The encapsulation of a GSM CBS message in CDMA messages may be achieved using various schemes. An indication is provided at each of a number of pertinent layers to allow the terminals to determine whether a GSM CBS message or a CDMA broadcast SMS message was sent. These indications include (1) a value in a designated field or subfield of a Data Burst Message, (2) a new value for a Category field in a Service Category parameter of an SMS Broadcast Message, and (3) a new value for a Msg_Encoding field in a User Data subparameter of the SMS Deliver Message.
Compound 526821: 13-Hydroxy-heptadecanoic acid, methyl ester, tBDMS ether

Chemical compound data from PubChem database. IUPAC Name: methyl 13-[tert-butyl(dimethyl)silyl]oxyheptadecanoate. Molecular Formula: C24H50O3Si. Molecular Weight: 414.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526797: 4-Hydroxy-nonadecanoic, gamma-lactone

Chemical compound data from PubChem database. IUPAC Name: 5-pentadecyloxolan-2-one. Molecular Formula: C19H36O2. Molecular Weight: 296.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526101: Tridecanoic acid, 8-methyl, trimethylsilyl ester

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 8-methyltridecanoate. Molecular Formula: C17H36O2Si. Molecular Weight: 300.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Quality Incentive Pool (QIP) Program Data (Years 1 - 5)

Beginning with the July 1, 2017, rating period, the Department implemented a managed care Designated Public Hospital (DPH) Quality Incentive Pool (QIP). The Department directed Managed Care Plans (MCPs) to make QIP payments tied to performance on designated performance metrics in four strategic categories: primary care, specialty care, inpatient care, and resource utilization. The datasets includes available data from DPHs’ annual reports, which include self-reported data on performance of QIP required metrics.  Data can be viewed via the download button.
New York State Donate Life Registry Enrollment by Zip Code

This dataset contains monthly snapshots of the number of enrollments by zip code in the New York State Donate Life Registry beginning in September 2008.  The registry is a confidential database that records a person’s consent to organ/tissue donation upon death. The database is used by donation professionals to determine a person's donation status at the time of their death. For more information, please visit https://donatelife.ny.gov/.
Compound 528635: Propanamide, N-isopropyl-2,2-dimethyl

Chemical compound data from PubChem database. IUPAC Name: 2,2-dimethyl-N-propan-2-ylpropanamide. Molecular Formula: C8H17NO. Molecular Weight: 143.23. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401159-T1: [Translated] METHOD FOR CONTROLLING AND/OR REGULATING A WELDING PROCESS

The invention relates to a method for controlling and/or adjusting a welding process, using a melting welding wire (13) wherein after ignition of an electric arc, a welding process is carried out, the welding process being adjusted on the basis of several different welding parameters and being controlled or adjusted by a control device and/or welding current source. In order to determine the position of distance between the end of the welding wire (13) and the workpiece (16), which is to be processed, in a manner which is as accurate as possible, at least one mechanical adjustment process (41) is carried out during the welding process, enabling the position of said welding wire (13) being used as a sensor.
NNDSS - TABLE 1T. Invasive pneumococcal disease, Age<5 years, Confirmed to Legionellosis

NNDSS - TABLE 1T. Invasive pneumococcal disease, age<5 years, Confirmed to Legionellosis - 2021. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents.

Notice: Due to data processing issues at CDC, data for the following jurisdictions may be incomplete for week 7: Alaska, Arizona, California, Connecticut, Delaware, Florida, Hawaii, Louisiana, Maryland, Michigan, Missouri, North Dakota, New Hampshire, New York City, Oregon, Pennsylvania, and Rhode Island.

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. 

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published.
NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
Cum: Cumulative year-to-date counts.
 Max: Maximum — Maximum case count during the previous 52 weeks.
  * Case counts for reporting years 2020 and 2021 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf. 
†Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data). 
§ Includes drug resistant and susceptible cases of Invasive Pneumococcal Disease.
Ethacrynic acid

Ethacrynic Acid is a prescription loop diuretic medication that helps increase urine production to reduce fluid buildup in the body, often used for conditions like edema or high blood pressure. It comes as 25 mg oral tablets manufactured by Lupin Pharmaceuticals, Inc., and was approved in February 2020 under ANDA211719. This information was generated using AI and is provided for informational and research purposes only.
Emergency Temporary Shelters - Limited Stay Exits - By Shelter and Date

Under <a href="https://chicityclerkelms.chicago.gov/Matter/?matterId=6DEAA6D8-D0E6-EE11-904C-001DD806E058" target="_blank">SO2024-0008386</a>, passed by City Council on 4/17/2024, the Department of Family and Support Services publishes data on the City-operated and City-funded emergency new arrivals shelters. This series of datasets contains data related to the <a href="https://www.chicago.gov/city/en/sites/texas-new-arrivals/home/faqs.html" target="_blank">Limited Stay Policy</a>. This dataset shows the total number of migrants who exited each shelter under this policy, each day.
Cellulose acetate phthalate, a common pharmaceutical excipient, inactivates HIV-1 and blocks the coreceptor binding site on the virus envelope glycoprotein gp120

Background
          Cellulose acetate phthalate (CAP), a pharmaceutical excipient used for enteric film coating of capsules and tablets, was shown to inhibit infection by the human immunodeficiency virus type 1 (HIV-1) and several herpesviruses. CAP formulations inactivated HIV-1, herpesvirus types 1 (HSV-1) and 2 (HSV-2) and the major nonviral sexually transmitted disease (STD) pathogens and were effective in animal models for vaginal infection by HSV-2 and simian immunodeficiency virus.
        
        
          Methods
          Enzyme-linked immunoassays and flow cytometry were used to demonstrate CAP binding to HIV-1 and to define the binding site on the virus envelope.
        
        
          Results
          1) CAP binds to HIV-1 virus particles and to the envelope glycoprotein gp120; 2) this leads to blockade of the gp120 V3 loop and other gp120 sites resulting in diminished reactivity with HIV-1 coreceptors CXCR4 and CCR5; 3) CAP binding to HIV-1 virions impairs their infectivity; 4) these findings apply to both HIV-1 IIIB, an X4 virus, and HIV-1 BaL, an R5 virus.
        
        
          Conclusions
          These results provide support for consideration of CAP as a topical microbicide of choice for prevention of STDs, including HIV-1 infection.
National Survey on Drug Use and Health (NSDUH-2013)

<p>The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health-related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2013 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For the 2008 survey, adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. In 2008, a split-sample design also was included to administer separate sets of questions (WHODAS vs. SDS) to assess impairment due to mental health problems. Beginning with the 2009 NSDUH, however, all of the adults in the sample received only the WHODAS questions. Background information includes sex, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. This study has 1 Data Set.</p>
Demographic and Geographic Variations in Injection Drug Use

Research indicates that the use of injectable drugs, like the use of other illicit drugs, varies by demographic group and geographic area. Methamphetamine use from 2002 to 2004, for example, was more prevalent in the West than in other regions of the country. Analysis of 2003 treatment admissions involving clients who injected their drugs of abuse showed that their profiles by race/ethnicity, gender, and region varied depending on the types of drugs they injected. These findings suggest that there are differences in the rates of injection drug use depending on demographic and geographic characteristics.
CCWIS Contracting and Procurement Webinar Part Two

CCWIS Contracting and Procurement Part Two Webinar is the second installment of a 2-part webinar series which covered strategies regarding Acquisition approach (e.g., Agile, performance-based contracting, “...as a Service”), Drafting statements of work and the definition of “done,” Customization versus configuration, Intellectual property (IP) and, Contract language around warranties and IP.

Metadata-only record linking to the original dataset. Open original dataset below.
Patent AT-E399522-T1: [Translated] HYDROGEL ADHESIVES FOR USE ON FIBER-COVERED SURFACES

The present invention relates to the use, for adhesion on hair or fiber-populated surfaces, of hydrogel adhesive characterized by a G'<SUB>25</SUB>, (1 rad/sec) or below 1000 Pa, resulting in embedding of the hair of fiber and good adhesion properties on the surface. The invention also encompasses Personal Care Products and Surface Care Articles containing the hydrogel compositions herein.
Encephalomeningocele cases over 10 years in Thailand: a case series

Background
          Encephalomeningocele, especially in the frontoethmoidal region, is a form of neural tube defect which affects patients in Southeast Asia more commonly than in Western countries. Its underlying cause is not known but teratogenic environmental agents are suspected. However, nutritional deficiency, as in spina bifida, cannot be excluded.
        
        
          Methods
          This study reports 21 cases of meningocele (without brain tissue in the lesion) and encephalomeningocele (with brain tissue) that were admitted to our hospital for surgical corrections in the period of ten years, from 1990 to 1999. Clinicopathological findings, as well as occupations of family members and prenatal exposures to infectious agents or chemicals were reviewed and analyzed.
        
        
          Results
          The most commonly involved area was the frontoethmoidal region, found in 20 cases. The combined pattern between nasoethmoidal and nasoorbital defects was found most frequently (11 from 21 cases) and had more associated abnormalities. Encephalomeningocele had more related abnormalities than meningocele with proportions of 0.6 and 0.3, respectively.
        
        
          Conclusions
          Here, we confirmed that genetic defects are not likely to be the single primary cause of this malformation. However, we could not draw any conclusions on etiologic agents. We suggest that case control studies and further investigation on the role of nutritional deficiencies, especially folic acid, in the pathogenesis of encephalomeningocele are necessary to clarify the underlying mechanisms.
Resolution of Pulmonary Inflammation Induced by Carbon Nanotubes and Fullerenes in Mice: Role of Macrophage Polarization

Exposure to certain engineered nanomaterials (ENMs) causes chronic lesions like lung fibrosis and cancer as a result of unresolved inflammation. Elucidating how ENM-induced inflammation is resolved is necessary for better evaluation of the fibrogenic and tumorigenic potentials of ENMs. This study aimed to identify pro-resolving mechanisms by analyzing the inflammatory and fibrogenic responses to multi-walled carbon nanotubes (MWCNTs, Mitsui-7) and fullerenes (fullerene C60, C60F) in B6C3F1 mice. The findings reveal that MWCNTs at a low dose (40 µg/mouse) and C60F at a high dose (>480 mg/mouse) stimulated acute neutrophilic inflammation, which exhibited rapid initiation and extended resolution. The lesion in MWCNT-exposed mice progressed to fibrotic granulomas by day 28 post-exposure, whereas it remained as alveolar histiocytosis in C60F-exposed mice. The ENMs induced high levels of proinflammatory lipid mediators leukotriene B4 (LTB4) and prostaglandin E2 (PGE2) with peaks at day 1, and high levels of special